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Short title:
Fetal intrapericardial teratoma: natural history and management
Condensation:
Fetal intrapericardial teratoma can be characterized and monitored through fetal echocardiography with successful management in utero including fetal surgical resection with survival to term.
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ABSTRACT
Background:
Intrapericardial teratoma is a rare, lethal tumor often detected in fetal life. Tumor mass and pericardial effusion cause cardiac tamponade, which if relieved, could be life-saving. Optimal timing of intervention and methods for effective fetal treatment are unknown.
Objectives:
We describe our single center experience with fetal intrapericardial teratoma including the first report of successful in utero surgical resection with survival to term.
Methods:
We reviewed our database for suspected fetal intrapericardial teratoma. On fetal ultrasound and echocardiography tumor size was estimated by calculation of an ellipse and analyzed in relation to Doppler-derived fetal cardiac output, venous flow patterns, hydrops and outcome.
Results:
Eight fetuses with suspected intrapericardial teratoma were seen between 2009 and 2015.
Gestational age at initial presentation ranged from 21-34 (median 26) weeks. Two cases mimicked the appearance of intrapericardial teratoma, but had no serial change in cardiac output over time and were ultimately determined to be other types of tumor. In 6 cases of true intrapericardial teratoma, tumor growth was extremely rapid and was associated with progressive decline in cardiac output (to < 400 cc/kg/min) manifesting in hydrops and death if left untreated. One case was treated successfully at 31 weeks through ex-utero intrapartum delivery with tumor resection while on placental support. Another case underwent open fetal M A N U S C R I P T
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surgery and resection at 24 weeks, with resumption of gestation until delivery at 37 weeks with excellent outcome.
Conclusions:
Fetal intrapericardial teratoma can be successfully managed utilizing serial surveillance and by treatment in a timely manner prior to the predictable onset of hydrops, determined through increasing tumor size and a declining cardiac output. Surgical resection in utero is possible, with good result.
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INTRODUCTION
Teratoma arising from the pericardium is an extremely rare tumor comprised of endodermal, mesodermal and ectodermal germinal cell lines 1 . Treatment is readily achieved through surgical resection with low incidence of recurrence 2, 3 . However, when intrapericardial teratoma is detected in fetal life, mortality is high. Tumor size can be large and associated with pericardial effusion, the combination of which leads to progressive constraint of filling, cardiac tamponade, fetal hydrops and death 4 .
Treatment of fetal intrapericardial teratoma before birth is a challenge. To date, management most often includes observation with temporizing measures of pericardial fluid drainage 5, 6 or delivery, once the fetus reaches a viable gestational age for postnatal surgical resection 7-9 .
Prenatal resection, if possible, would be an ideal means of treatment. Open fetal surgery for resection of lung lesions is feasible with good results, when performed for impending hydrops prior to onset of severe hemodynamic compromise 10 . A previous attempt at removal of a intrapericardial teratoma in a hydropic fetus did not result in survival 11 . Markers characterizing the course and predicting in-utero deterioration would be helpful in guidance and timing of effective treatment strategies.
The aims of this study are to report our experience with fetal intrapericardial teratoma, offer insight into monitoring by fetal echocardiography and report on the application of innovative 
RESULTS
Between 2009 and 2015, eight cases of suspected fetal intrapericardial teratoma were identified (Table 1) . Gestational age at initial presentation ranged from 21-34 (median 26) weeks. Serial fetal evaluations with two or more assessments were made in 5 patients; only 1 evaluation was performed in each of 3 patients (cases 2, 7, 8) presenting with severe hydrops.
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All cases had moderate to large circumferential pericardial effusion at initial presentation. In Case 5 presented in a 23 year old woman at 34 weeks gestation. A large irregularly shaped mass was noted in the left chest, compressing the left atrium and left ventricle and encasing the ascending aorta as it extended anteriorly and cephalad. There was a large pericardial effusions and the tumor was quite large, yet there was no hydrops and no change in size of the mass during 3 weeks of follow-up. Elective delivery was undertaken at 37 weeks gestation, and at cardiac surgery a large encapsulated tumor extending into the upper left mediastinum, not adherent to any part of the heart, was noted. The pericardium was opened and a large bloody effusion drained. The tumor was mobilized and found to arise from the ascending aorta, above the sino-tubular junction, extended onto the underside of the arch and was adherent to the aortic wall. During dissection, the aorta was entered and cardiopulmonary bypass (CPB)
initiated. After resection, homograft patch reconstruction of the aorta was performed. The patient could not be separated from CPB and after a period of support with extracorporeal membrane oxygenation, expired.
Case 6 presented in a 31 year old woman at 33 weeks gestation. An irregularly shaped tumor associated with a large pericardial effusion was noted in the right atrioventricular groove with appearance of compression of the right atrium. Serial evaluation over 4 weeks revealed minimal increase in tumor size and no signs of hydrops. Delivery was elected at 37 weeks and the infant was stable at birth. Surgery was performed in the first week of life and the tumor was noted to be inside the right atrium, adherent to and pushing out the right atrial free wall.
Excision was undertaken using CPB and pathology revealed hemangioma. 
